Provivi, the company developing biopesticides for agriculture, commercial and public health pest management, has raised $21M in Series B funding from Spruce Capital Partners, DuPont, Kairos Venture Investments and BASF Venture Capital. The company has raised $29.4M over 3 rounds of funding.
Page 4 of 4
